Iguana Healthcare Management’s Aerie Pharmaceuticals AERI Stock Holding History

Iguana Healthcare Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-85,000	Closed	-$5.08M	–	77
2017 Q4	$5.08M	Sell	85,000 -15,000	-15%	-$910K	3.31%	6
2017 Q3	$4.86M	Buy	100,000 +5,000	+5%	+$273K	2.65%	10
2017 Q2	$4.99M	Buy	95,000 +10,000	+12%	+$466K	2.82%	9
2017 Q1	$3.85M	Sell	85,000 -30,000	-26%	-$1.34M	1.91%	17
2016 Q4	$4.35M	Sell	115,000 -215,000	-65%	-$8.13M	2.6%	12
2016 Q3	$12.5M	Buy	330,000 +180,000	+120%	+$3.97M	2.22%	16
2016 Q2	$2.64M	Buy	150,000 +75,000	+100%	+$1.21M	1.07%	31
2016 Q1	$912K	Buy	+75,000	New	+$1.19M	0.33%	61
2015 Q4	–	Sell	-60,015	Closed	-$1.06M	–	87
2015 Q3	$1.06M	Buy	+60,015	New	+$1.09M	0.42%	57
2015 Q2	–	Sell	-120,000	Closed	-$3.76M	–	88
2015 Q1	$3.76M	Sell	120,000 -30,000	-20%	-$870K	1.58%	22
2014 Q4	$4.38M	Sell	150,000 -40,000	-21%	-$1.01M	2.12%	14
2014 Q3	$3.93M	Buy	190,000 +44,300	+30%	+$873K	2.1%	13
2014 Q2	$3.61M	Sell	145,700 -64,300	-31%	-$1.11M	1.68%	24
2014 Q1	$4.45M	Buy	210,000 +97,500	+87%	+$1.97M	2.06%	13
2013 Q4	$2.02M	Buy	+112,500	New	+$1.47M	1.15%	30

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's AERI Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2018, closing a stake of 85,000 shares — an estimated $5.08M sold.

Iguana Healthcare Management first reported a position in AERI in Q4 2013 and held it in 15 quarters. The position peaked at $12.5M in Q3 2016. 172 funds tracked by Wall St. Rank hold AERI as of Q1 2018.

Iguana Healthcare Management reported no remaining Aerie Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 85,000 Aerie Pharmaceuticals shares in Q1 2018, an estimated $5.08M.
Iguana Healthcare Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 15 quarters.
Iguana Healthcare Management's Aerie Pharmaceuticals position peaked at $12.5M in Q3 2016.
172 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.